“Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life”, RSD, vol. 14, no. 5, p. e4914548812, May 2025, doi: 10.33448/rsd-v14i5.48812.